WISE ancillary study data analyses:Efficacy of hormone replacement [ethinylestradiol/norethisterone] on myocardial ischemia in postmenopausal women with normal/minimal coronary artery disease: Data analysis

Trial Profile

WISE ancillary study data analyses:Efficacy of hormone replacement [ethinylestradiol/norethisterone] on myocardial ischemia in postmenopausal women with normal/minimal coronary artery disease: Data analysis

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Mar 2012

At a glance

  • Drugs Ethinylestradiol/norethisterone (Primary)
  • Indications Cardiovascular disorders; Menopausal syndrome
  • Focus Pharmacodynamics
  • Acronyms WISE
  • Most Recent Events

    • 28 Mar 2012 Planned End Date changed from 1 Jan 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.
    • 05 Aug 2009 Planned end date changed from 1 Dec 2009 to 1 Jan 2012 as reported by ClinicalTrials.gov.
    • 29 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top